Pfizer Recalls Birth Control Pills (PFE)
There is going to be some concerning news if you are on birth control pills made by Pfizer Inc. (NYSE: PFE). The drug giant is announcing a product recall of birth control…
There is going to be some concerning news if you are on birth control pills made by Pfizer Inc. (NYSE: PFE). The drug giant is announcing a product recall of birth control…
All three major indexes opened higher this morning, but the strength didn’t last as the Chicago PMI number failed to meet expectations and came in lower even than last month’s reading. The…
Pfizer, Inc. (NYSE: PFE) looks good on the surface on its earnings report for the fourth quarter, but the company’s guidance may be getting in the way a bit. The drug giant…
Tuesday is going to be full of major earnings reports, two of which are DJIA components. These are not the only major earnings, but ten we will be watching closely are as…
Pfizer Inc. (NYSE: PFE) has received approval from the US Food and Drug Administration to sell its kidney cancer drug, Inlyta, in the US. The drug is expected to generate about $140…
Jim Cramer has touted several DJIA upside calls in 2012, but on Monday’s MAD MONEY on CNBC Cramer touted Merck & Company, Inc. (NYSE: MRK) as the great pharma outfit with what may…
The tide of patent expirations that is washing over big pharmaceutical houses is cresting now and investors have begun looking forward to how these companies will deal with some sharp blows to…
A state appeals court in Pennsylvania has sided with two women who filed suit against drugmaker Pfizer Inc. (NYSE: PFE) claiming that the company’s Prempro menopause drug caused their breast cancers. The…
For several years it has been the case that Amgen Inc. (NASDAQ: AMGN) was considered a biotech though it had at least some of the same problems of Big Pharma players like Pfizer Inc.…
As each new year replaces the prior year, 24/7 Wall St. looks at the individual targets on all 30 Dow Jones Industrial Average price targets from Wall Street analysts to come up…
The lineup of the Dogs of the Dow, simply the ten highest dividend yield stocks of the thirty Dow Jones Industrial Average components, appears to be undergoing a bit of change for…
Throughout December we have been giving updates on dividends that will rise in the coming days and weeks from the 30 Dow Jones Industrial Average stocks. Many have already come true and…
Spending on advertising barely showed a pulse in the third quarter of 2011, growing by just 0.4%, according a report from Kantar Media cited in The New York Times. Spending growth has…
Congress, close to a budget agreement, may avoid a government shutdown. (Reuters) Washington Mutual shareholders and creditors set a deal that could allow an exit from bankruptcy. (Reuters) The policy meeting of…
We recently gave a full review of the DJIA components we expect to raise their dividend payouts in the weeks and months ahead. Among those we expect to raise the dividend is…